{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T11:25:54Z","timestamp":1790162754002,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Inter-ministerial Mission for Combating Drugs and Addictive Behaviors (MILDECA)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Subst Abuse Treat Prev Policy"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13011-017-0131-4","type":"journal-article","created":{"date-parts":[[2017,11,2]],"date-time":"2017-11-02T12:02:20Z","timestamp":1509624140000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Willingness to receive intravenous buprenorphine treatment in opioid-dependent people refractory to oral opioid maintenance treatment: results from a community-based survey in France"],"prefix":"10.1186","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5069-4982","authenticated-orcid":false,"given":"Perrine","family":"Roux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Rojas Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khadim","family":"Ndiaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"La\u00e9lia","family":"Briand Madrid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Laporte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Mora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwenaelle","family":"Maradan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Morel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Spire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Carrieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,2]]},"reference":[{"issue":"1\u20132","key":"131_CR1","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.drugalcdep.2008.03.025","volume":"97","author":"P Roux","year":"2008","unstructured":"Roux P, Villes V, Blanche J, Bry D, Spire B, Feroni I, et al. Buprenorphine in primary care: risk factors for treatment injection and implications for clinical management. Drug Alcohol Depend. 2008;97(1\u20132):105\u201313. PubMed PMID: 18479840","journal-title":"Drug Alcohol Depend"},{"issue":"Suppl 1","key":"131_CR2","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1080\/10550490490440780","volume":"13","author":"M Auriacombe","year":"2004","unstructured":"Auriacombe M, Fatseas M, Dubernet J, Daulouede JP, Tignol J. French field experience with buprenorphine. Am J Addict. 2004;13(Suppl 1):S17\u201328. PubMed PMID: 15204673","journal-title":"Am J Addict"},{"issue":"Suppl 4","key":"131_CR3","doi-asserted-by":"publisher","first-page":"S197","DOI":"10.1086\/508184","volume":"43","author":"MP Carrieri","year":"2006","unstructured":"Carrieri MP, Amass L, Lucas GM, Vlahov D, Wodak A, Woody GE. Buprenorphine use: the international experience. Clin Infect Dis. 2006;43(Suppl 4):S197\u2013215. \nhttps:\/\/doi.org\/10.1086\/508184\n\n. PubMed PMID: 17109307","journal-title":"Clin Infect Dis"},{"issue":"11","key":"131_CR4","doi-asserted-by":"publisher","first-page":"e112328","DOI":"10.1371\/journal.pone.0112328","volume":"9","author":"PM Carrieri","year":"2014","unstructured":"Carrieri PM, Michel L, Lions C, Cohen J, Vray M, Mora M, et al. Methadone induction in primary care for opioid dependence: a pragmatic randomized trial (ANRS Methaville). PLoS One. 2014;9(11):e112328. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0112328\n\n. PubMed PMID: 25393311; PubMed Central PMCID: PMC4231094","journal-title":"PLoS One"},{"key":"131_CR5","first-page":"CD002207","volume":"2","author":"RP Mattick","year":"2014","unstructured":"Mattick RP, Breen C, Kimber J, Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev. 2014;2:CD002207. PubMed PMID: 24500948","journal-title":"Cochrane Database Syst Rev"},{"key":"131_CR6","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.drugalcdep.2016.02.035","volume":"162","author":"J Delorme","year":"2016","unstructured":"Delorme J, Chenaf C, Kabore JL, Pereira B, Mulliez A, Tremey A, et al. Incidence of high dosage buprenorphine and methadone shopping behavior in a retrospective cohort of opioid-maintained patients in France. Drug Alcohol Depend. 2016;162:99\u2013106. \nhttps:\/\/doi.org\/10.1016\/j.drugalcdep.2016.02.035\n\n. PubMed PMID: 27006272","journal-title":"Drug Alcohol Depend"},{"key":"131_CR7","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.drugalcdep.2015.09.026","volume":"156","author":"S Lake","year":"2015","unstructured":"Lake S, Hayashi K, Buxton J, Milloy MJ, Dong H, Wood E, et al. The effect of prescription opioid injection on the risk of non-fatal overdose among people who inject drugs. Drug Alcohol Depend. 2015;156:297\u2013303. \nhttps:\/\/doi.org\/10.1016\/j.drugalcdep.2015.09.026\n\n. PubMed PMID: 26454837; PubMed Central PMCID: PMC4633348","journal-title":"Drug Alcohol Depend"},{"issue":"5","key":"131_CR8","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1159\/000346179","volume":"19","author":"H Peyriere","year":"2013","unstructured":"Peyriere H, Eiden C, Micallef J, Lapeyre-Mestre M, Faillie JL, Blayac JP. Slow-release oral morphine sulfate abuse: results of the postmarketing surveillance systems for psychoactive prescription drug abuse in France. Eur Addict Res. 2013;19(5):235\u201344. \nhttps:\/\/doi.org\/10.1159\/000346179\n\n. PubMed PMID: 23428846","journal-title":"Eur Addict Res"},{"issue":"1","key":"131_CR9","doi-asserted-by":"crossref","first-page":"28","DOI":"10.2174\/1874473711104010028","volume":"4","author":"MA Yokell","year":"2011","unstructured":"Yokell MA, Zaller ND, Green TC, Rich JD. Buprenorphine and buprenorphine\/naloxone diversion, misuse, and illicit use: an international review. Curr Drug Abuse Rev. 2011;4(1):28\u201341. PubMed PMID: 21466501; PubMed Central PMCID: PMC3154701","journal-title":"Curr Drug Abuse Rev"},{"issue":"1\u20132","key":"131_CR10","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.drugalcdep.2008.08.016","volume":"100","author":"R Dwyer","year":"2009","unstructured":"Dwyer R, Topp L, Maher L, Power R, Hellard M, Walsh N, et al. Prevalences and correlates of non-viral injecting-related injuries and diseases in a convenience sample of Australian injecting drug users. Drug Alcohol Depend. 2009;100(1\u20132):9\u201316. \nhttps:\/\/doi.org\/10.1016\/j.drugalcdep.2008.08.016\n\n. PubMed PMID: 19013725","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"131_CR11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2133.2004.05607.x","volume":"150","author":"P Del Giudice","year":"2004","unstructured":"Del Giudice P. Cutaneous complications of intravenous drug abuse. Br J Dermatol. 2004;150(1):1\u201310. PubMed PMID: 14746612","journal-title":"Br J Dermatol"},{"issue":"2","key":"131_CR12","doi-asserted-by":"publisher","first-page":"182","DOI":"10.2515\/therapie\/2013073","volume":"69","author":"C Diot","year":"2014","unstructured":"Diot C, Eiden C, Lenoir H, Chammas M, Xatart S, Leglise Y, et al. Necrotizing fasciitis related to injections of morphine (Skenan((R))) in a HIV-infected patient. Therapie. 2014;69(2):182\u20135. \nhttps:\/\/doi.org\/10.2515\/therapie\/2013073\n\n. PubMed PMID: 24926640","journal-title":"Therapie"},{"issue":"2","key":"131_CR13","first-page":"327","volume":"3","author":"D Shlomi","year":"2008","unstructured":"Shlomi D, Shitrit D, Bendayan D, Sahar G, Shechtman Y, Kramer MR. Successful lung transplantation for talcosis secondary to intravenous abuse of oral drug. Int J Chron Obstruct Pulmon Dis. 2008;3(2):327\u201330. PubMed PMID: 18686743","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"10","key":"131_CR14","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1136\/jcp.25.10.876","volume":"25","author":"D Lamb","year":"1972","unstructured":"Lamb D, Roberts G. Starch and talc emboli in drug addicts\u2019 lungs. J Clin Pathol. 1972;25(10):876\u201381. PubMed PMID: 4566961","journal-title":"J Clin Pathol"},{"issue":"1","key":"131_CR15","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1378\/chest.78.1.90","volume":"78","author":"BF Waller","year":"1980","unstructured":"Waller BF, Brownlee WJ, Roberts WC. Self-induced pulmonary granulomatosis. A consequence of intravenous injection of drugs intended for oral use. Chest. 1980;78(1):90\u20134. PubMed PMID: 7471850","journal-title":"Chest"},{"key":"131_CR16","doi-asserted-by":"publisher","unstructured":"Roux P, Le Gall JM, Debrus M, Protopopescu C, Ndiaye K, Demoulin B, et al. Innovative community-based educational face-to-face intervention to reduce HIV, hepatitis C virus and other blood-borne infectious risks in difficult-to-reach people who inject drugs: results from the ANRS-AERLI intervention study. Addiction 2016;111(1):94-106. doi: \nhttps:\/\/doi.org\/10.1111\/add.13089\n\n. PubMed PMID: 26234629.","DOI":"10.1111\/add.13089"},{"key":"131_CR17","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1192\/bjp.bp.106.026112","volume":"191","author":"C Haasen","year":"2007","unstructured":"Haasen C, Verthein U, Degkwitz P, Berger J, Krausz M, Naber D. Heroin-assisted treatment for opioid dependence: randomised controlled trial. Br J Psychiatry. 2007;191:55\u201362. \nhttps:\/\/doi.org\/10.1192\/bjp.bp.106.026112\n\n. PubMed PMID: 17602126","journal-title":"Br J Psychiatry"},{"issue":"9729","key":"131_CR18","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1016\/S0140-6736(10)60349-2","volume":"375","author":"J Strang","year":"2010","unstructured":"Strang J, Metrebian N, Lintzeris N, Potts L, Carnwath T, Mayet S, et al. Supervised injectable heroin or injectable methadone versus optimised oral methadone as treatment for chronic heroin addicts in England after persistent failure in orthodox treatment (RIOTT): a randomised trial. Lancet. 2010;375(9729):1885\u201395. \nhttps:\/\/doi.org\/10.1016\/S0140-6736(10)60349-2\n\n. PubMed PMID: 20511018","journal-title":"Lancet"},{"issue":"8","key":"131_CR19","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1056\/NEJMoa0810635","volume":"361","author":"E Oviedo-Joekes","year":"2009","unstructured":"Oviedo-Joekes E, Brissette S, Marsh DC, Lauzon P, Guh D, Anis A, et al. Diacetylmorphine versus methadone for the treatment of opioid addiction. N Engl J Med. 2009;361(8):777\u201386. PubMed PMID: 19692689","journal-title":"N Engl J Med"},{"issue":"4","key":"131_CR20","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1159\/000369337","volume":"21","author":"I Demaret","year":"2015","unstructured":"Demaret I, Quertemont E, Litran G, Magoga C, Deblire C, Dubois N, et al. Efficacy of heroin-assisted treatment in Belgium: a randomised controlled trial. Eur Addict Res. 2015;21(4):179\u201387. \nhttps:\/\/doi.org\/10.1159\/000369337\n\n. PubMed PMID: 25832522","journal-title":"Eur Addict Res"},{"issue":"1","key":"131_CR21","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1192\/bjp.bp.114.149195","volume":"207","author":"J Strang","year":"2015","unstructured":"Strang J, Groshkova T, Uchtenhagen A, van den Brink W, Haasen C, Schechter MT, et al. Heroin on trial: systematic review and meta-analysis of randomised trials of diamorphine-prescribing as treatment for refractory heroin addictiondagger. Br J Psychiatry. 2015;207(1):5\u201314. \nhttps:\/\/doi.org\/10.1192\/bjp.bp.114.149195\n\n. PubMed PMID: 26135571","journal-title":"Br J Psychiatry"},{"issue":"1","key":"131_CR22","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12954-017-0152-3","volume":"14","author":"S Boyd","year":"2017","unstructured":"Boyd S, Murray D, SNAP, MacPherson D. Telling our stories: heroin-assisted treatment and SNAP activism in the downtown eastside of Vancouver. Harm Reduct J. 2017;14(1):27. \nhttps:\/\/doi.org\/10.1186\/s12954-017-0152-3\n\n. PubMed PMID: 28521781; PubMed Central PMCID: PMCPMC5437683","journal-title":"Harm Reduct J"},{"key":"131_CR23","series-title":"National Institute for health and medical research (INSERM)","volume-title":"Reducing risks of infection amongst drug users : synthesis and recommendations","author":"INSERM","year":"2010","unstructured":"INSERM. Reducing risks of infection amongst drug users : synthesis and recommendations. National Institute for health and medical research (INSERM), 2010."},{"issue":"3","key":"131_CR24","first-page":"281","volume":"57","author":"M Kahan","year":"2011","unstructured":"Kahan M, Srivastava A, Ordean A, Cirone S. Buprenorphine: new treatment of opioid addiction in primary care. Can Fam Physician. 2011;57(3):281\u20139. doi: 57\/3\/281 [pii]. Epub 16 Mar 2011. PubMed PMID: 21402963; PubMed Central PMCID: PMC3056674","journal-title":"Can Fam Physician"},{"issue":"5","key":"131_CR25","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1097\/ADM.0000000000000045","volume":"8","author":"MR Lofwall","year":"2014","unstructured":"Lofwall MR, Walsh SL. A review of buprenorphine diversion and misuse: the current evidence base and experiences from around the world. J Addict Med. 2014;8(5):315\u201326. \nhttps:\/\/doi.org\/10.1097\/ADM.0000000000000045\n\n. PubMed PMID: 25221984; PubMed Central PMCID: PMC4177012","journal-title":"J Addict Med"},{"issue":"5","key":"131_CR26","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1111\/fcp.12210","volume":"30","author":"H Peyriere","year":"2016","unstructured":"Peyriere H, Nogue E, Eiden C, Frauger E, Charra M, Picot MC, et al. Evidence of slow-release morphine sulfate abuse and diversion: epidemiological approaches in a French administrative area. Fundam Clin Pharmacol. 2016;30(5):466\u201375. \nhttps:\/\/doi.org\/10.1111\/fcp.12210\n\n. PubMed PMID: 27315486","journal-title":"Fundam Clin Pharmacol"},{"key":"131_CR27","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1186\/1471-2458-10-327","volume":"10","author":"E Lloyd-Smith","year":"2010","unstructured":"Lloyd-Smith E, Wood E, Zhang R, Tyndall MW, Sheps S, Montaner JS, et al. Determinants of hospitalization for a cutaneous injection-related infection among injection drug users: a cohort study. BMC Public Health. 2010;10:327. PubMed PMID: 20534148","journal-title":"BMC Public Health"},{"issue":"5","key":"131_CR28","doi-asserted-by":"publisher","first-page":"770","DOI":"10.2105\/AJPH.2004.057828","volume":"96","author":"E Wood","year":"2006","unstructured":"Wood E, Tyndall MW, Qui Z, Zhang R, Montaner JS, Kerr T. Service uptake and characteristics of injection drug users utilizing North America's first medically supervised safer injecting facility. Am J Public Health. 2006;96(5):770\u20133. \nhttps:\/\/doi.org\/10.2105\/AJPH.2004.057828\n\n. PubMed PMID: 16571703; PubMed Central PMCID: PMC1470579","journal-title":"Am J Public Health"},{"key":"131_CR29","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.drugalcdep.2014.10.012","volume":"145","author":"C Potier","year":"2014","unstructured":"Potier C, Laprevote V, Dubois-Arber F, Cottencin O, Rolland B. Supervised injection services: what has been demonstrated? A systematic literature review. Drug Alcohol Depend. 2014;145:48\u201368. \nhttps:\/\/doi.org\/10.1016\/j.drugalcdep.2014.10.012\n\n. PubMed PMID: 25456324","journal-title":"Drug Alcohol Depend"},{"key":"131_CR30","doi-asserted-by":"publisher","unstructured":"Islam MM, Topp L, Conigrave KM, van Beek I, Maher L, White A, et al. The reliability of sensitive information provided by injecting drug users in a clinical setting: clinician-administered versus audio computer-assisted self-interviewing (ACASI). AIDS Care 2012;24(12):1496-1503. doi: \nhttps:\/\/doi.org\/10.1080\/09540121.2012.663886\n\n. PubMed PMID: 22452446.","DOI":"10.1080\/09540121.2012.663886"},{"issue":"3","key":"131_CR31","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0376-8716(98)00028-3","volume":"51","author":"S Darke","year":"1998","unstructured":"Darke S. Self-report among injecting drug users: a review. Drug Alcohol Depend. 1998;51(3):253\u201363. discussion 67-8. PubMed PMID: 9787998","journal-title":"Drug Alcohol Depend"},{"issue":"5","key":"131_CR32","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/sj.npp.1301479","volume":"33","author":"SD Comer","year":"2008","unstructured":"Comer SD, Sullivan MA, Whittington RA, Vosburg SK, Kowalczyk WJ. Abuse liability of prescription opioids compared to heroin in morphine-maintained heroin abusers. Neuropsychopharmacology. 2008;33(5):1179\u201391. PubMed PMID: 17581533","journal-title":"Neuropsychopharmacology"},{"issue":"30","key":"131_CR33","first-page":"1433","volume":"26","author":"G Decocq","year":"1997","unstructured":"Decocq G, Fremaux D, Smail A, Compagnon M, Andrejak M. Local complications after intravenous injection of dissolved tablets of buprenorphine. Presse Med. 1997;26(30):1433. PubMed PMID: 9404358","journal-title":"Presse Med"},{"issue":"22","key":"131_CR34","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1056\/NEJMp1402780","volume":"370","author":"ND Volkow","year":"2014","unstructured":"Volkow ND, Frieden TR, Hyde PS, Cha SS. Medication-assisted therapies--tackling the opioid-overdose epidemic. N Engl J Med. 2014;370(22):2063\u20136. \nhttps:\/\/doi.org\/10.1056\/NEJMp1402780\n\n. PubMed PMID: 24758595","journal-title":"N Engl J Med"},{"issue":"2","key":"131_CR35","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1360-0443.2009.02754.x","volume":"105","author":"P Blanken","year":"2010","unstructured":"Blanken P, Hendriks VM, van Ree JM, van den Brink W. Outcome of long-term heroin-assisted treatment offered to chronic, treatment-resistant heroin addicts in the Netherlands. Addiction. 2010;105(2):300\u20138. PubMed PMID: 19922517","journal-title":"Addiction"}],"container-title":["Substance Abuse Treatment, Prevention, and Policy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13011-017-0131-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,11,2]],"date-time":"2017-11-02T12:02:33Z","timestamp":1509624153000},"score":1,"resource":{"primary":{"URL":"http:\/\/substanceabusepolicy.biomedcentral.com\/articles\/10.1186\/s13011-017-0131-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,2]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["131"],"URL":"https:\/\/doi.org\/10.1186\/s13011-017-0131-4","relation":{},"ISSN":["1747-597X"],"issn-type":[{"value":"1747-597X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,2]]},"article-number":"46"}}